Optimizing : PK in drug development
PK strategy is dose individualization, tailoring drug doses to the specific characteristics of patients. Population PK modeling allows researchers to analyze data from diverse patient populations, identifying factors such as age, gender, and genetic variations that influence drug metabolism and clearance. By accounting for these individual differences, drug developers can design dosing regimens that optimize drug exposure for various patient groups, ultimately maximizing efficacy while minimizing the risk of adverse effects.
Website : https://pumas.ai/pumasCP
Like
Comment
Share
